Phase 4 N=88 Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis
Diarrhea
Primary: Duration of Diarrhea — 2; 2 days — p=0.43
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=147 Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis
Diarrhea
Primary: Number of Participants That Were Successfully Rehydrated — 57; 49 Participants — p=0.28
Phase 2 N=57 Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide
Malignant Glioma
Primary: Safety and Tolerability of Palonosetron as Determined by the Number of Participants Who Experience Unacceptable Toxicity — 5 participants
Phase 3 N=817 Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
Bipolar Depression
Primary: Number of Participants With Serious and Non-serious Treatment-emergent Adverse Events Who Have Completed 24 Weeks of Extension Study Treatment — 529 participants
Phase 3 N=102 Periodontal Infection and Endothelial Dysfunction
Periodontitis
Primary: Brachial Artery Flow-mediated Dilation — 10.2; 10.3; 13.1; 8.1 Percentage of dilatation of brachial art — p=0.98
Phase 2 N=154 Study of Phosphate Levels in Patients With Chronic Kidney Disease
Chronic Kidney Disease
Primary: Change From Baseline in Serum-phosphate Levels at the End of Treatment. — -0.042; -0.348; -0.404; -0.644 mmol/L
Phase 3 N=1,059 A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
Chronic Kidney Disease Requiring Chronic Dialysis
Primary: Change in Serum Phosphorus Levels From Week 24 to Week 27 — 0.25; 1.92 mg/dL
Phase 3 N=513 Clinical Trial Ceftriaxone in Subjects With ALS
Amyotrophic Lateral Sclerosis · ALS
Primary: Survival — 664; 581 days
Phase 2 N=103 Bortezomib in Treating Patients With Lymphoproliferative Disorders
Recurrent Grade 1 Follicular Lymphoma · Recurrent Grade 2 Follicular Lymphoma · Recurrent Grade 3 Follicular Lymphoma
Primary: Response Rate — 11; 6 participants
Phase 2 N=6 Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)
Alternating Hemiplegia of Childhood
Primary: Time Duration of AHC Episodes
Phase 3 N=838 Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Influenza · Influenza Vaccines
Primary: Number of Subjects Seroprotected for Haemagglutination Inhibition (HI) Antibody Titers Against the H5N1 A/Indonesia Virus Strain. — 175; 184; 201; 0 Subject
Phase 3 N=639 Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes
Major Depressive Disorder
Primary: Relapse Within First 24 Weeks of the Double-blind Period Based on a MADRS Total Score >=22 or an Unsatisfactory Treatment Effect (Lack of Efficacy) as Judged by the…
Phase 3 N=579 Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
Neoplasms, Breast
Primary: Time to Progression as Evaluated by the Investigator — 29.0; 22.9 weeks — p=0.142
Phase 2 N=16 Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)
Idiopathic Solar Urticaria
Primary: Assessment of the Minimal Urticaria Dose (MUD) on Each Test Site, After Application of the Test Products — 4.33; 3.93; 3.80; 3.67 Photodermatosis Protection Factor
N/A N=10 Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair
Problem With Vision Blindness · Intraocular Pressure · Ischemic Optic Neuropathy
Primary: Right Intraocular Pressure During Various Event Intervals in Open Abdominal Aortic Aneurysm Surgery. — 16.9; 13.8; 14.6; 13.5 mm Hg — p=<0.001